Aptose Biosciences Inc.

  • Home
  • About
    • Overview
    • Management Team
    • Board of Directors
    • Scientific Advisory Board
  • Product Pipeline
    • Overview
    • Tuspetinib for AML
    • Luxeptinib for B-cell Tumors
    • Luxeptinib for Myeloid Tumors
    • Posters & Presentations
  • Clinical Trials
    • Overview
    • Luxeptinib for CLL & NHL
    • Luxeptinib for AML
    • Tuspetinib for AML
    • Expanded Access
  • News
    • Press Releases
    • Presentations
    • Events
  • Investors
    • Overview
    • News & Events
    • Company Info
    • Financial Info
    • Stock Data
    • SEC Filings
    • SEDAR
    • Governance
  • Join Us
    • Values & Culture
    • Perks & Benefits
    • Explore Careers
  • Contact

Press Releases

Investors

Investors

  • Overview
  • News & Events
    • Overview
    • Press Releases
    • IR Calendar
    • Email Alerts
  • Company Info
    • Overview
    • Management Team
    • Presentations
    • Contacts
  • Financial Info
    • Overview
    • Financial Results
    • Income Statement
    • Cash Flow
  • Stock Data
    • TSX: APS
    • Analyst Coverage
  • SEC Filings
    • Overview
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • SEDAR
  • Governance
    • Overview
    • Board of Directors
    • Board Committees
    • Governance Documents
  • News & Events

  • Overview
  • Press Releases
  • IR Calendar
  • Email Alerts

Aptose Announces Appointment of Caroline M. Loewy to Board of Directors

Apr 25, 2018 7:00am EDT

Aptose to Present at the Bloom Burton & Co. Healthcare Investor Conference 2018

Apr 24, 2018 7:00am EDT

Aptose Presents Preclinical Data on APTO-253 at 2018 AACR Annual Meeting

Apr 17, 2018 2:00pm EDT

OHSU and Aptose Present New CG’806 Preclinical Data at 2018 AACR Annual Meeting

Apr 16, 2018 7:30am EDT

Aptose Presents New Preclinical Data on CG’806 Pan-FLT3/ Pan-BTK Inhibitor at 2018 AACR Annual Meeting

Apr 16, 2018 7:30am EDT

Aptose to Present at the H.C. Wainwright Annual Global Life Sciences Conference

Apr 03, 2018 8:00am EDT

Aptose Biosciences Establishes New At-the-Market Facility

Mar 28, 2018 8:00am EDT

Aptose Reports Results for the Fourth Quarter and Year Ended December 31, 2017

Mar 27, 2018 4:15pm EDT

Aptose to Present New CG’806 and APTO-253 Data at the 2018 AACR Annual Meeting

Mar 15, 2018 7:05am EDT

Aptose To Release Fourth Quarter and Year End December 31, 2017 Financial Results and Hold Conference Call on March 27, 2018

Mar 08, 2018 7:00am EST
RSS
  • Prev
    • 1...
    • 18
    • 19
    • 20
    • 21
    • 22
    • 23
    • 24
    • 25
    • 26
    • 27
    • ...32
    Next
    • Email Alerts
    • Contacts
    • RSS News Feed
    © 2025 Aptose Biosciences Inc. All Rights Reserved.
    Privacy Policy Clinical Trials Policy Disclaimer Sitemap Manage Cookie Preferences